From: mdanderson.org Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted therapies, tucatinib and trastuzumab, plus the chemotherapy drug, capecitabine, may improve symptoms and extend survival in some breast cancer patients with LM. The Phase II study, published today in Nature Cancer, included 17 female patients with newly diagnosed LM and HER2+ breast cancer. Median overall survival (OS) in those treated with the combination therapy increased from a historical average of 4.4 months to 10 months. …
Culturally tailored videos may help inform breast cancer screening
By: Amerigo Allegretto From: auntminnie.co Culturally adapted informational video may improve breast cancer knowledge among patients, suggest findings published March 13 in PEC Innovation. A 12-minute video intervention led to increased self-efficacy and mammography screening intention for a mostly Hispanic study population, wrote a team of researchers led by Priyanka Dadha, PhD, from Texas Tech University in El Paso. “The culturally …
Telehealth visits may help breast cancer patients stay on treatment
By: Sydney Barrilleaux, University of Georgia From: medicalxpress.com Staying in touch with doctors online could help breast cancer survivors keep up their cancer treatment, according to a recent study from the University of Georgia published in the Journal of Cancer Survivorship. After chemotherapy and surgery, most breast cancer survivors are prescribed oral endocrine therapy to prevent the disease from coming …
What Options Do Patients With Breast Cancer Have After Mastectomy?
By: Bridget Hoyt From: oncnursingnews.com Mastectomy can have major impacts on the life of a person with breast cancer, from body image issues to sexual and psychosocial well-being, many of which are caused or amplified by mastectomy. Counselling patients on what their options are after mastectomy, including reconstructive surgery, is an essential part of cancer treatment and should be included …
A new triple negative breast cancer target: Why HORMAD1 could guide treatment choices
By: Institute of Cancer Research From: medicalxpress.com A gene that is typically active only in reproductive cells may hold the key to new treatments for triple negative breast cancer, according to new research published in the journal Nature Communications. Scientists from the Breast Cancer Now Toby Robins Research Center at The Institute of Cancer Research, London (ICR) and the Breast …
USPSTF guidelines lead to shifted views on breast cancer screening
By: Amerigo Allegretto From: auntminnie.com omen’s views on breast cancer screening may have shifted due to guideline changes in breast cancer screening, according to research published March 10 in Patient Education and Counseling. Exposure to guideline information updated in 2024 by the U.S. Preventive Services Task Force (USPSTF) led many women to adjust their breast cancer screening preferences to align …
Can Local Therapy Extend Life in Metastatic Breast Cancer?
By: Frederik Joelving From: medscape.com Women with de novo metastatic breast cancer that is confined to a single distant organ may live longer when they undergo resection of the primary tumor, a large cohort study suggested. The study, of over 22,000 US women with the diagnosis, found that while local therapies were uncommon, they were associated with longer overall survival: …
Unusual Tumor Cells May Be Overlooked Factors in Advanced Breast Cancer
From: cornell.edu An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The findings highlight the potential importance of these under-studied cells in breast cancer progression. Circulating tumors cells are breakaway tumor cells …
Why ‘being squeezed’ helps breast cancer cells to thrive
By: University of Adelaide From: medicalxpress.com A new study led by researchers at Adelaide University and published in Science Advances reveals why some cancers can grow and survive in the body, while others cannot. It turns out that intense mechanical pressure experienced by early cancer cells as they grow cramped in a restricted space can benefit some cancer cells, rather …
Alternative breast cancer treatment tied to about four times higher mortality, nationwide analysis finds
By: Sanjukta Mondal From: medicalxpress.com The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social media. This growing trend has become an increasing concern for oncology practitioners and patients, as it can affect treatment decisions and trust in evidence-based care. The worry isn’t unfounded, as a recent study involving patients with …